New scheme to help improve diabetes care in Nottingham

A new project to help people with diabetes in Nottingham has been launched. The scheme will aim to reduce the amount of hospital admissions needed for diabetes treatment, and also improve the healthcare offered to the 12,800 diabetics in the city.
The Nottingham NHS and Industry Maximising Resources and Outcomes in Diabetes (NIMROD) project will focus on identifying any common factors that contributes hospital admission for diabetes, and reviewing potential improvements to current treatment guidelines and service provision. It hopes to lower the amount of unplanned admissions to hospitals and encourage and support people with diabetes to self-manage their condition where possible.
NIMROD is being run by a range of organisations such as NHS Nottingham City (PCT), Nottingham University and Hospitals NHS Trust, as well as pharmaceutical companies including Lilly UK, Novo Nordisk, AstraZenecan, Novartis and Pfizer .
Jan Balmer, project manager for NIMROD, commented “All the partners in this project have a shared interest in improving people’s health and reducing their need for hospital treatment. By pooling our skills, experiences and resources we can benefit patients to make sure people with diabetes get the best available care and, where possible, help them avoid hospitalisation altogether.”
Barbara Young, the chief executive of the charity Diabetes UK, who endorsed the schemen, also said “Diabetes UK is delighted to be involved in this exciting and innovative project, which will ultimately reduce unacceptable variations in standards of diabetes care and improve outcomes for people with diabetes in Nottingham.”